1. Home
  2. ASM vs ENTA Comparison

ASM vs ENTA Comparison

Compare ASM & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASM
    SELLHOLDBUYas of 2 days ago
  • ENTA
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • ASM 1968
  • ENTA 1995
  • Country
  • ASM Canada
  • ENTA United States
  • Employees
  • ASM N/A
  • ENTA N/A
  • Industry
  • ASM Metal Mining
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASM Basic Materials
  • ENTA Health Care
  • Exchange
  • ASM Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • ASM 146.2M
  • ENTA 129.3M
  • IPO Year
  • ASM N/A
  • ENTA 2013
  • Fundamental
  • Price
  • ASM $0.94
  • ENTA $5.58
  • Analyst Decision
  • ASM Strong Buy
  • ENTA Buy
  • Analyst Count
  • ASM 2
  • ENTA 4
  • Target Price
  • ASM $1.80
  • ENTA $17.25
  • AVG Volume (30 Days)
  • ASM 1.2M
  • ENTA 687.8K
  • Earning Date
  • ASM 11-12-2024
  • ENTA 02-05-2025
  • Dividend Yield
  • ASM N/A
  • ENTA N/A
  • EPS Growth
  • ASM 144.19
  • ENTA N/A
  • EPS
  • ASM 0.02
  • ENTA N/A
  • Revenue
  • ASM $54,326,000.00
  • ENTA $67,635,000.00
  • Revenue This Year
  • ASM $40.31
  • ENTA $11.80
  • Revenue Next Year
  • ASM $33.83
  • ENTA $3.99
  • P/E Ratio
  • ASM $37.27
  • ENTA N/A
  • Revenue Growth
  • ASM 18.08
  • ENTA N/A
  • 52 Week Low
  • ASM $0.44
  • ENTA $5.30
  • 52 Week High
  • ASM $1.56
  • ENTA $17.80
  • Technical
  • Relative Strength Index (RSI)
  • ASM 43.45
  • ENTA 26.63
  • Support Level
  • ASM $0.85
  • ENTA $5.30
  • Resistance Level
  • ASM $0.99
  • ENTA $6.10
  • Average True Range (ATR)
  • ASM 0.05
  • ENTA 0.40
  • MACD
  • ASM 0.00
  • ENTA 0.05
  • Stochastic Oscillator
  • ASM 36.60
  • ENTA 22.22

Stock Price Comparison Chart: ASM vs ENTA

ASM
ENTA
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100ASM VS ENTA

About ASM Avino Silver & Gold Mines Ltd. (Canada)

Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use